ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells

International Journal of Cancer

Volumn 130, Issue 7, 2012, Pages 1532-1543

  Llauradõ, Marta ^a   Abal, Miguel ^a   Castellví, Josep ^b   Cabrera, Sílvia ^a,b   Gil Moreno, Antonio ^b,c   Pérez Benavente, Asumpciõ ^b   Colás, Eva ^a   Doll, Andreas ^a   Dolcet, Xavier ^d   Matias Guiu, Xavier ^d   Vazquez Levin, Mõnica ^e   Reventõs, Jaume ^a,c   Ruiz, Anna ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF LLEIDA   (Spain)

^e Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

ETS transcription factors; ETV5; ovarian cancer; tumor dissemination

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CELL ADHESION; CONTROLLED STUDY; ETV5 GENE; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; METASTASIS; MIGRATION INHIBITION; OVARY CANCER; PRIORITY JOURNAL; TUMOR GENE; UPREGULATION;

APOPTOSIS; CADHERINS; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DNA-BINDING PROTEINS; DOWN-REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PERITONEAL CAVITY; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84856328897     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26148     Document Type: Article

References (42)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics. CA Cancer J Clin 2010; 60: 277-300.
2. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC,. Current management strategies for ovarian cancer. Mayo Clin Proc 2007; 82: 751-70. (Pubitemid 46878099)
3. Sementchenko VI, Watson DK,. Ets target genes: past, present and future. Oncogene 2000; 19: 6533-48. (Pubitemid 32108443)
4. Sharrocks AD,. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2001; 2: 827-37. (Pubitemid 33674083)
5. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T,. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003; 253: 269-85.
6. Davidson B, Reich R, Risberg B, Nesland JM,. The biological role and regulation of matrix metalloproteinases (MMP) in cancer. Arkh Patol 2002; 64: 47-53.
7. Chang C, Werb Z,. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001; 11: S37-S43.
8. de Launoit Y, Baert JL, Chotteau-Lelievre A, Monte D, Coutte L, Mauen S, Firlej V, Degerny C, Verreman K,. The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis. Biochim Biophys Acta 2006; 1766: 79-87. (Pubitemid 44202569)
9. Graves BJ, Petersen JM,. Specificity within the ets family of transcription factors. Adv Cancer Res 1998; 75: 1-55. (Pubitemid 28429032)
10. Habelhah H, Okada F, Kobayashi M, Nakai K, Choi S, Hamada J, Moriuchi T, Kaya M, Yoshida K, Fujinaga K, Hosokawa M,. Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression. Oncogene 1999; 18: 1771-6. (Pubitemid 29137468)
11. Hida K, Shindoh M, Yoshida K, Kudoh A, Furaoka K, Kohgo T, Fujinaga K, Totsuka Y,. Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma. Oral Oncol 1997; 33: 426-30. (Pubitemid 28126041)
12. Shindoh M, Higashino F, Kohgo T,. E1AF, an ets-oncogene family transcription factor. Cancer Lett 2004; 216: 1-8. (Pubitemid 39410490)
13. Hiroumi H, Dosaka-Akita H, Yoshida K, Shindoh M, Ohbuchi T, Fujinaga K, Nishimura M,. Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion. Int J Cancer 2001; 93: 786-91. (Pubitemid 32761692)
14. Planaguma J, Abal M, Gil-Moreno A, Diaz-Fuertes M, Monge M, Garcia A, Baro T, Xercavins J, Reventos J, Alameda F,. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma. J Pathol 2005; 207: 422-9. (Pubitemid 43025690)
15. Planaguma J, Diaz-Fuertes M, Gil-Moreno A, Abal M, Monge M, Garcia A, Baro T, Thomson TM, Xercavins J, Alameda F, Reventos J,. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Cancer Res 2004; 64: 8846-53. (Pubitemid 39665488)
16. Monge M, Colas E, Doll A, Gonzalez M, Gil-Moreno A, Planaguma J, Quiles M, Arbos MA, Garcia A, Castellvi J, Llaurado M, Rigau M, et al. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Cancer Res 2007; 67: 6753-9. (Pubitemid 47105522)
17. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R,. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma. Clin Cancer Res 2003; 9: 1412-9. (Pubitemid 36418395)
18. Cowden Dahl KD, Zeineldin R, Hudson LG,. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Mol Cancer Res 2007; 5: 413-21. (Pubitemid 46903950)
19. Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM,. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin Cancer Res 2001; 7: 551-7. (Pubitemid 32707977)
20. Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Trope CG, Kristensen GB, Bryne M, Reich R,. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome. Am J Surg Pathol 2001; 25: 1493-500. (Pubitemid 33096963)
21. Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema TR, Jr., Ruff LE, Skubitz AP,. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol 2001; 159: 2071-80. (Pubitemid 33104261)
22. Seth A, Watson DK,. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005; 41: 2462-78. (Pubitemid 41540623)
23. Thiery JP, Acloque H, Huang RY, Nieto MA,. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-90.
24. Yilmaz M, Christofori G,. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33.
25. Naora H, Montell DJ,. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005; 5: 355-66. (Pubitemid 40637827)
26. Burleson KM, Boente MP, Pambuccian SE, Skubitz AP,. Disaggregation and invasion of ovarian carcinoma ascites spheroids. J Transl Med 2006; 4: 6.
27. Fouquet S, Lugo-Martinez VH, Faussat AM, Renaud F, Cardot P, Chambaz J, Pincon-Raymond M, Thenet S,. Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes. J Biol Chem 2004; 279: 43061-9. (Pubitemid 39372201)
28. Kantak SS, Kramer RH,. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 1998; 273: 16953-61. (Pubitemid 28311727)
29. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC,. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001; 22: 255-88. (Pubitemid 32458162)
30. Sundfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brannstrom M, Janson PO, Enerback S, Hedin L,. E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int J Cancer 1997; 74: 275-80. (Pubitemid 27321795)
31. Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR, Jr., Skubitz AP,. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol 2004; 93: 170-81. (Pubitemid 38429567)
32. Burleson KM, Hansen LK, Skubitz AP,. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Clin Exp Metastasis 2004; 21: 685-97.
33. Lessan K, Aguiar DJ, Oegema T, Siebenson L, Skubitz AP,. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 1999; 154: 1525-37. (Pubitemid 29226447)
34. Sloan KA, Marquez HA, Li J, Cao Y, Hinds A, O'Hara CJ, Kathuria S, Ramirez MI, Williams MC, Kathuria H,. Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines. Carcinogenesis 2009; 30: 1433-42.
35. Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, Ng T, Reynolds CP, Triche TJ, Sorensen PH,. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 2007; 67: 3094-105. (Pubitemid 46724846)
36. Kantak SS, Kramer RH,. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 1998; 273: 16953-61. (Pubitemid 28311727)
37. Elloul S, Vaksman O, Stavnes HT, Trope CG, Davidson B, Reich R,. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions. Clin Exp Metastasis 2010; 27: 161-72.
38. Yoshida J, Horiuchi A, Kikuchi N, Hayashi A, Osada R, Ohira S, Shiozawa T, Konishi I,. Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Med Mol Morphol 2009; 42: 82-91.
39. Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY, Drescher CW, Urban N, Knudsen BS, Tewari M,. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol 2010; 116: 117-25.
40. Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V,. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol 2000; 192: 460-9.
41. Lengyel E,. Ovarian cancer development and metastasis. Am J Pathol 2010; 177: 1053-64.
42. Shield K, Riley C, Quinn MA, Rice GE, Ackland ML, Ahmed N,. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J Carcinog 2007; 6: 11.